HK1088594A1 - Novel compounds and methods for synthesis and therapy - Google Patents

Novel compounds and methods for synthesis and therapy

Info

Publication number
HK1088594A1
HK1088594A1 HK06109031A HK06109031A HK1088594A1 HK 1088594 A1 HK1088594 A1 HK 1088594A1 HK 06109031 A HK06109031 A HK 06109031A HK 06109031 A HK06109031 A HK 06109031A HK 1088594 A1 HK1088594 A1 HK 1088594A1
Authority
HK
Hong Kong
Prior art keywords
therapy
synthesis
methods
novel compounds
novel
Prior art date
Application number
HK06109031A
Other languages
English (en)
Inventor
Norbert W Bischofberger
Choung U Kim
Willard Lew
Hongtao Liu
Matthew A Williams
Original Assignee
Gilead Sciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/476,946 external-priority patent/US5866601A/en
Application filed by Gilead Sciences Inc filed Critical Gilead Sciences Inc
Publication of HK1088594A1 publication Critical patent/HK1088594A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
HK06109031A 1995-02-27 2006-08-15 Novel compounds and methods for synthesis and therapy HK1088594A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US39524595A 1995-02-27 1995-02-27
US08/476,946 US5866601A (en) 1995-02-27 1995-06-06 Carbocyclic compounds
US58056795A 1995-12-29 1995-12-29

Publications (1)

Publication Number Publication Date
HK1088594A1 true HK1088594A1 (en) 2006-11-10

Family

ID=39638544

Family Applications (3)

Application Number Title Priority Date Filing Date
HK02106752.3A HK1046359B (zh) 1995-02-27 2002-09-13 神經氨酸苷酶抑制劑
HK06109031A HK1088594A1 (en) 1995-02-27 2006-08-15 Novel compounds and methods for synthesis and therapy
HK08112143.3A HK1120494A1 (en) 1995-02-27 2008-11-06 Novel compounds and methods for synthesis and therapy

Family Applications Before (1)

Application Number Title Priority Date Filing Date
HK02106752.3A HK1046359B (zh) 1995-02-27 2002-09-13 神經氨酸苷酶抑制劑

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK08112143.3A HK1120494A1 (en) 1995-02-27 2008-11-06 Novel compounds and methods for synthesis and therapy

Country Status (10)

Country Link
EP (1) EP0976734B1 (xx)
JP (1) JP2008273948A (xx)
CN (3) CN103772231B (xx)
CA (2) CA2546660C (xx)
CL (1) CL2004001291A1 (xx)
DK (1) DK0976734T3 (xx)
GE (1) GEP20074226B (xx)
HK (3) HK1046359B (xx)
HU (1) HU229200B1 (xx)
NZ (1) NZ520724A (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6518048B2 (en) * 2000-04-10 2003-02-11 Hoffmann-La Roche Inc. Stereo-specific synthesis of shimikic acid derivatives with improved efficiency
CZ301813B6 (cs) 2000-06-27 2010-06-30 F. Hoffmann-La Roche Ag Zpusob prípravy farmaceutické kompozice
EP2145010A1 (en) 2007-04-13 2010-01-20 Monsanto Technology, LLC Use of glyphosate to produce shikimic acid in microorganisms
WO2009052303A2 (en) 2007-10-16 2009-04-23 Monsanto Technology Llc Processes for producing and recovering shikimic acid
CN103845316B (zh) * 2012-11-30 2016-07-06 北京普禄德医药科技有限公司 神经氨酸苷酶抑制剂及其前药的制药用途
US11014964B2 (en) * 2017-07-21 2021-05-25 Sichuan Haisco Pharmaceutical Co., Ltd. Peptide amide compound and preparation method and medical use thereof
CN109504973A (zh) * 2019-01-09 2019-03-22 奎克化学（中国）有限公司 一种用于轧钢领域的酸洗缓蚀剂的表面活性剂

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP249A (en) * 1990-04-24 1993-03-17 Biota Scient Management Pty Ltd Anti-viral compounds.
WO1992006691A1 (en) * 1990-10-19 1992-04-30 Biota Scientific Management Pty. Ltd. Anti-viral compounds that bind the active site of influenza neuramidase and display in vivo activity against orthomyxovirus and paramyxovirus
CA2081068C (en) * 1991-10-23 2005-11-29 Laurence Mark Von Itzstein Antiviral 4-substituted-2-deoxy-2,3-didehydro-derivatives of .alpha.-d-neuraminic acid
GB9126725D0 (en) * 1991-12-17 1992-02-12 Glaxo Group Ltd Process
AUPM354694A0 (en) * 1994-01-27 1994-02-17 Biota Scientific Management Pty Ltd Chemical compounds
AUPM725794A0 (en) * 1994-08-03 1994-08-25 Biota Scientific Management Pty Ltd Chemical compounds

Also Published As

Publication number Publication date
CN102952033A (zh) 2013-03-06
CA2546660C (en) 2009-08-11
HK1046359A1 (en) 2003-01-10
CA2188835A1 (en) 1996-09-06
CN101172957A (zh) 2008-05-07
EP0976734B1 (en) 2005-09-28
DK0976734T3 (da) 2005-12-27
HU229200B1 (en) 2013-09-30
CN101172957B (zh) 2012-11-14
HK1120494A1 (en) 2009-04-03
CL2004001291A1 (es) 2005-05-06
GEP20074226B (en) 2007-10-25
JP2008273948A (ja) 2008-11-13
CN103772231A (zh) 2014-05-07
CA2546660A1 (en) 1996-09-06
EP0976734A3 (en) 2000-03-22
EP0976734A2 (en) 2000-02-02
NZ520724A (en) 2004-03-26
HK1046359B (zh) 2009-05-08
CN103772231B (zh) 2016-02-03
CA2188835C (en) 2006-08-08

Similar Documents

Publication Publication Date Title
ZA9811314B (en) Novel compounds and methods for synthesis and therapy
AU5268696A (en) Novel compounds and methods for therapy
GB2304196B (en) Electroconvulsive therapy
IL114162A0 (en) Submersive therapy apparatus
SG44952A1 (en) Therapeutic amides
IL143517A0 (en) Novel synthesis
GB9526546D0 (en) Compounds useful in therapy
EP0833630A4 (en) NOVEL BENZOPYRAN COMPOUNDS AND METHODS OF USING THE SAME
EP0766940A4 (en) BED
EP0851759A4 (en) COMPOUNDS AND RELATED METHODS
GB9520124D0 (en) Audio synthesizer
EP0744231A3 (en) Fixing device
HK1120494A1 (en) Novel compounds and methods for synthesis and therapy
GB9516309D0 (en) Novel compounds and process
GB9515868D0 (en) Therapeutic method
IL129868A0 (en) Process for the synthesis of benzothiopenes
GB9504876D0 (en) Compounds and process
IL118238A0 (en) Synthesis of benzoquinolinones
AU2003204079A1 (en) Novel compounds and methods for synthesis and therapy
ZA988451B (en) Novel compounds and methods for synthesis and therapy
IL113555A0 (en) Process for the synthesis of haloalkylferrocenes
EG21037A (en) Process for the synthesis of benzathiophenes
GB9523558D0 (en) Therapeutic compounds
GB9523801D0 (en) Therapeutic compounds
GB9526110D0 (en) Therapeutic compounds

Legal Events

Date Code Title Description
PE Patent expired

Effective date: 20160225